Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Journal of Cardiac Failure|November 5, 2023
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection FractionRobin Ray, Ian Ford, John G F Cleland, et al.
Heart (British Cardiac Society)|February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trialShirley Sze, Iain Squire, Paul R Kalra, et al.
European Journal of Heart Failure|October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trialPaul W Foley, Paul R Kalra, John G F Cleland, et al.
European Journal of Heart Failure|May 24, 2024
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESCGiuseppe M C Rosano, Davide Stolfo, Lisa Anderson, et al.
Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.
European Journal of Heart Failure|March 17, 2025
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESCDavide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, et al.
European Journal of Heart Failure|May 23, 2024
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESCGianluigi Savarese, Felix Lindberg, Antonio Cannata, et al.
European Journal of Heart Failure|March 2, 2026
SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart FailureRoss T Campbell, Joanna Osmanska, Kieran F Docherty, et al.
European Journal of Heart Failure|October 17, 2020
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failurePetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
European Journal of Heart Failure|October 6, 2021
COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of CardiologyGiuseppe Rosano, Ewa A Jankowska, Robin Ray, et al.
Pageof 18